Pii Home >  

First in Man Fast
Formulation Services

Pii understands the need to reduce development costs and enter the clinic quickly to establish efficacy. For fast in man enabling studies, Pii offers API in a capsule filling capabilities using Capsugel's Xcelodose®. The Xcelodose system is a precision powder micro-doser and automated encapsulator that allows the direct fill of API into capsules. By eliminating the need for excipients and drug product analytical methods development, Xcelodose can dramatically shorten time to clinic for first in man studies.

Poorly Soluble Compounds
As the number of NCE's with poor solubility continues to increase, Pii offers extensive expertise in finding formulation solutions for improving the bioavailability of poorly soluble compounds. Pii's formulation development capabilities include:

Pii is here to help you at every step of the development pathway, offering a range of services with the customer service and advice you need to move your project forward. Our scientists can screen different solid forms, characterize and select the best candidate for development, develop early phase formulations and manufacture cGMP clinical material.

Solid-State Chemistry

Pii offers a comprehensive package of advanced solid-state screening, characterization and interpretation services to support the development of new and existing active drug substances and drug product formulations. Solid state screening services include:

At Pii we understand the value of your API. Using state-of-the-art technologies we provide the data you need with rapid turnaround using minimal drug substance. Our combination of experienced staff and high-throughput technologies, provide you with the insight you need to make an informed decision about your development strategy.

Characterization Tools Include:

Our industry leading transmission X-ray powder diffraction provides a resource unparalleled in the contract service industry, especially when used in conjunction with our Raman capabilities. Multiple DSC, TGA GVS instruments, a wealth of supporting services and robotics ensure the capacity to take on your project and provide you with the best and most rapid service at great value.

 

Learn more about Pii's Early Phase Development services, including Solid State Screening capabilities, visit us at booth 1721 during INFORMEX 2012, complete the contact form below or contact us at (410) 584-0001.

Pii at Informex 2012

* Required fields.      
* First Name: * Address:
* Last Name: * City:
* Job Title: * State/Prov:
* Company: * ZIP/Postal Code:
* Phone: * Country:
* E-Mail: Area of Interest:
     
 

About Pii:

Pharmaceutics International, Inc. (Pii) is a privately held contract development and manufacturing company providing dosage form development and GMP manufacturing services to the global pharmaceutical industry. Pii's vision is to become the benchmark in pharmaceutical product development and commercial manufacturing outsourcing. Headquartered in Hunt Valley, Maryland USA with European facilities in the UK, Pii offers preformulation testing, formulation development, clinical and commercial GMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms.

About Pharmaterials:

Pharmaterials Ltd, a division of Pii, is a pharmaceutical contract service company with comprehensive expertise in solid state screening, pharmaceutical materials science and formulation development for oral, inhaled and parenteral routes of drug delivery. Located in Reading, UK, Pharmaterial's MHRA approved cGMP facility manufactures clinical materials for phase I clinical studies.

410-584-0001  www.pharm-int.com

United States 10819 Gilroy Road, Hunt Valley, MD 21031, USA, 410-584-0001
Europe Unit B, 5, Boulton Road, Reading, RG2 0NH,,UK, +44 (0) 1189 209900


©Copyright 2011 Pharmaceutics International, Inc. All Rights Reserved.